These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12840678)

  • 41. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Fattahi MR; Malek-Hosseini SA; Sivandzadeh GR; Safarpour AR; Bagheri Lankarani K; Taghavi AR; Ejtehadi F
    Inflamm Bowel Dis; 2017 Jul; 23(7):1160-1167. PubMed ID: 28520586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
    Bosch DE; Yeh MM
    Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis.
    Hanouneh IA; Macaron C; Lopez R; Zein NN; Lashner BA
    Inflamm Bowel Dis; 2012 Feb; 18(2):269-74. PubMed ID: 21425212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.
    Sokol H; Cosnes J; Chazouilleres O; Beaugerie L; Tiret E; Poupon R; Seksik P
    World J Gastroenterol; 2008 Jun; 14(22):3497-503. PubMed ID: 18567077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
    Rudolph G; Gotthardt D; Kloeters-Plachky P; Rost D; Kulaksiz H; Stiehl A
    J Hepatol; 2010 Aug; 53(2):313-7. PubMed ID: 20472317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.
    Claessen MM; Lutgens MW; van Buuren HR; Oldenburg B; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Siersema PD; Vleggaar FP
    Inflamm Bowel Dis; 2009 Sep; 15(9):1331-6. PubMed ID: 19229982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
    Ngu JH; Gearry RB; Wright AJ; Stedman CA
    Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis].
    Villamil A; De Paula JA; Galdame O; Piccioni H; Ciardullo M; De Santibañes E; Gadano A
    Acta Gastroenterol Latinoam; 2008 Dec; 38(4):252-9. PubMed ID: 19157380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis.
    Irlès-Depé M; Roullet S; Neau-Cransac M; Dumortier J; Dharancy S; Houssel-Debry P; Boillot O; Chiche L; Laurent C; Laharie D; De Lédinghen V
    Liver Transpl; 2020 Nov; 26(11):1477-1491. PubMed ID: 32603007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Concurrent Non-IBD Immunological Diseases on the Outcome of Primary Sclerosing Cholangitis.
    Jegadeesan R; Navaneethan U; Bharadwaj S; Hammel J; Sanaka MR; Shen B
    Inflamm Bowel Dis; 2016 Apr; 22(4):948-54. PubMed ID: 26950311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity of ulcerative colitis before and after liver transplantation in primary sclerosing cholangitis: the Hungarian experience.
    Gelley F; Miheller P; Péter A; Telkes G; Nemes B
    Transplant Proc; 2012 Sep; 44(7):2164-5. PubMed ID: 22974943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
    Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune-mediated diseases in primary sclerosing cholangitis.
    Lamberts LE; Janse M; Haagsma EB; van den Berg AP; Weersma RK
    Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation.
    Aranake-Chrisinger J; Dassopoulos T; Yan Y; Nalbantoglu I
    World J Gastroenterol; 2020 Jul; 26(28):4126-4139. PubMed ID: 32821074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
    Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    de Krijger M; Carvalho B; Rausch C; Bolijn AS; Delis-van Diemen PM; Tijssen M; van Engeland M; Mostafavi N; Bogie RMM; Dekker E; Masclee AAM; Verheij J; Meijer GA; Ponsioen CY
    Inflamm Bowel Dis; 2022 Sep; 28(9):1309-1320. PubMed ID: 35554535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation.
    Knechtle SJ; D'Alessandro AM; Harms BA; Pirsch JD; Belzer FO; Kalayoglu M
    Surgery; 1995 Oct; 118(4):615-9; discussion 619-20. PubMed ID: 7570313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.
    Dvorchik I; Subotin M; Demetris AJ; Fung JJ; Starzl TE; Wieand S; Abu-Elmagd KM
    Hepatology; 2002 Feb; 35(2):380-4. PubMed ID: 11826412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.
    Christensen B; Micic D; Gibson PR; Yarur A; Bellaguarda E; Corsello P; Gaetano JN; Kinnucan J; Rao VL; Reddy S; Singh S; Pekow J; Rubin DT
    Aliment Pharmacol Ther; 2018 Mar; 47(6):753-762. PubMed ID: 29377235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.